Iron removal with phlebotomy and recombinant human erythropoietin in secondary hemochromatosis after allogeneic bone marrow transplantation

被引：3
|
作者：
Cho, SJ
Lee, SJ
Yoo, ES
Ryu, KH
Seoh, JY
Hong, KS
Koo, H
机构：
[1] Ewha Womans Univ, Coll Med, Dept Pediat, Seoul 158710, South Korea
[2] Ewha Womans Univ, Coll Med, Dept Microbiol, Seoul 158710, South Korea
[3] Ewha Womans Univ, Coll Med, Dept Clin Pathol, Seoul 158710, South Korea
[4] Ewha Womans Univ, Coll Med, Dept Pathol, Seoul 158710, South Korea
来源：
PEDIATRICS INTERNATIONAL | 2006年 / 48卷 / 02期
关键词：
chronic graft versus host disease; iron removal; secondary hemochromatosis;
D O I：
10.1111/j.1442-200X.2006.02192.x
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：174 / 177
页数：4
相关论文
共 50 条
  • [1] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    LINK, H
    BRUNE, T
    HUBNER, G
    DIEDRICH, H
    FREUND, M
    STOLL, M
    PEEST, D
    EBELL, W
    BETTONI, C
    OSTER, W
    NICOLAY, U
    HEINRICHS, H
    [J]. ANNALS OF HEMATOLOGY, 1993, 67 (04) : 169 - 173
  • [2] Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation
    Fujimori, Y
    Kanamaru, A
    Saheki, K
    Mori, A
    Takatsuka, H
    Wada, H
    Okada, M
    Tamura, S
    Okamoto, T
    Takemoto, Y
    Kakishita, E
    Nagai, K
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 1998, 67 (02) : 131 - 136
  • [3] Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity
    J de la Serna
    R Bornstein
    M-J García-Bueno
    J-J Lahuerta-Palacios
    [J]. Bone Marrow Transplantation, 1999, 23 : 95 - 97
  • [4] Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity
    de la Serna, J
    Bornstein, R
    García-Bueno, MJ
    Lahuerta-Palacios, JJ
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (01) : 95 - 97
  • [5] RECOMBINANT-HUMAN-ERYTHROPOIETIN IS EFFECTIVE IN CORRECTING ERYTHROPOIETIN-DEFICIENT ANEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    LOCATELLI, F
    PEDRAZZOLI, P
    BAROSI, G
    ZECCA, M
    PORTA, F
    LIBERATO, L
    GAMBARANA, D
    NESPOLI, L
    CAZZOLA, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (04) : 545 - 549
  • [6] A PILOT TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLOBMT)
    MILLER, CB
    HUELSKAMP, AM
    MILLS, SR
    JONES, RJ
    [J]. EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 577 - 577
  • [7] Juvenile hemochromatosis associated with β-thalassemia treated by phlebotomy and recombinant human erythropoietin
    De Gobbi, M
    Pasquero, P
    Brunello, F
    Paccotti, P
    Mazza, U
    Camaschella, C
    [J]. HAEMATOLOGICA, 2000, 85 (08) : 865 - 867
  • [8] A CONTROLLED TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER BONE-MARROW TRANSPLANTATION
    LINK, H
    BOOGAERTS, MA
    FAUSER, AA
    SLAVIN, S
    REIFFERS, J
    GORIN, NC
    CARELLA, AM
    MANDELLI, F
    BURDACH, S
    FERRANT, A
    LINKESCH, W
    TURA, S
    BACIGALUPO, A
    SCHINDEL, F
    HEINRICHS, H
    [J]. BLOOD, 1994, 84 (10) : 3327 - 3335
  • [9] Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation
    Eisfeld, Ann-Kathrin
    Krahl, Rainer
    Jaekel, Nadja
    Niederwieser, Dietger
    Al-Ali, Haifa Kathrin
    [J]. AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (04): : 243 - 253
  • [10] Recombinant erythropoietin to reduce red blood cell transfusions in late anemia after allogeneic bone marrow transplantation
    Renges, H
    Kröger, N
    Krüger, W
    Wasilewski, F
    Zander, AR
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S162 - S162
12345